PPM1D mutations appear in complete remission after exposure to chemotherapy without predicting emerging AML relapse
- 15 February 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 35 (9), 2693-2697
- https://doi.org/10.1038/s41375-021-01155-y
Abstract
No abstract availableFunding Information
- Scholarship Ministry of Health, Oman
- KWF Kankerbestrijding (2015-7525)
This publication has 17 references indexed in Scilit:
- Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potentialNature Communications, 2018
- Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical OutcomesCell Stem Cell, 2017
- Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for LymphomaJournal of Clinical Oncology, 2017
- Acute Myeloid LeukemiaThe New England Journal of Medicine, 2015
- Somatic Mutations and Clonal Hematopoiesis in Aplastic AnemiaThe New England Journal of Medicine, 2015
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA SequenceThe New England Journal of Medicine, 2014
- Age-Related Clonal Hematopoiesis Associated with Adverse OutcomesThe New England Journal of Medicine, 2014
- Age-related mutations associated with clonal hematopoietic expansion and malignanciesNature Medicine, 2014
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaThe New England Journal of Medicine, 2013
- The Origin and Evolution of Mutations in Acute Myeloid LeukemiaCell, 2012